MTX-GFLG-Melittin

General Information


DRACP ID  DRACP06039

Peptide Name   MTX-GFLG-Melittin

Sequence  XGFLGGIGAVLKVLTTGLPALISWIKRKRQQ

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Targeted peptide conjugates



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X=Methotrexate

Chiral  L



Physicochemical Information


Formula  C150H252N42O35

Absent amino acids  CDEHMNY

Common amino acids  GL

Mass  384922

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  14

Net charge  5

Boman Index  -504

Hydrophobicity  41.61

Aliphatic Index  125.81

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  183.33

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN115317622A

Patent Title  Preparation and application of anti-tumor polypeptide coupling medicine

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.